| scholarly article | Q13442814 |
| P356 | DOI | 10.1128/JVI.02174-08 |
| P8608 | Fatcat ID | release_c4phog2kq5ecrm3ipxsmahqirm |
| P932 | PMC publication ID | 2655560 |
| P698 | PubMed publication ID | 19144714 |
| P50 | author | Kristy J Szretter | Q54435422 |
| David Swayne | Q67293866 | ||
| Jacqueline M. Katz | Q87082629 | ||
| Terrence M Tumpey | Q87490350 | ||
| Peter Staeheli | Q87800241 | ||
| Jessica A Belser | Q88489180 | ||
| Neal Van Hoeven | Q98196925 | ||
| P2093 | author name string | Hui Zeng | |
| P2860 | cites work | Influenza virus transmission is dependent on relative humidity and temperature | Q21090528 |
| H5N1 viruses and vaccines | Q21131612 | ||
| Evolution of H5N1 avian influenza viruses in Asia | Q21559381 | ||
| Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals | Q22255464 | ||
| The pathology of influenza virus infections | Q22255608 | ||
| Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7 | Q24533409 | ||
| Interferon-inducible antiviral effectors | Q27486790 | ||
| Pathogenicity of a Hong Kong-origin H5N1 highly pathogenic avian influenza virus for emus, geese, ducks, and pigeons | Q28211637 | ||
| N-acetylcysteine synergizes with oseltamivir in protecting mice from lethal influenza infection | Q28236065 | ||
| Avian influenza A (H5N1) infection in humans | Q28274603 | ||
| Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern | Q28275022 | ||
| Three Indonesian clusters of H5N1 virus infection in 2005 | Q28275435 | ||
| Characterization of the reconstructed 1918 Spanish influenza pandemic virus | Q28275911 | ||
| Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus | Q28283850 | ||
| A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission | Q28286390 | ||
| Family clustering of avian influenza A (H5N1) | Q28292551 | ||
| H5N1 Virus Attachment to Lower Respiratory Tract | Q28303460 | ||
| Probable person-to-person transmission of avian influenza A (H5N1) | Q28304014 | ||
| Oseltamivir resistance during treatment of influenza A (H5N1) infection | Q29618722 | ||
| Avian flu: influenza virus receptors in the human airway | Q29619374 | ||
| A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans | Q30233717 | ||
| Influenza virus neuraminidase inhibitors | Q30305461 | ||
| Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza | Q30331304 | ||
| Confronting the avian influenza threat: vaccine development for a potential pandemic. | Q30342476 | ||
| Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice. | Q30351073 | ||
| Avian flu: isolation of drug-resistant H5N1 virus. | Q30351638 | ||
| The guinea pig as a transmission model for human influenza viruses | Q30355013 | ||
| Protection from lethal influenza virus challenge by oral type 1 interferon. | Q30360002 | ||
| Antiviral strategies against human coronaviruses. | Q30360255 | ||
| Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice. | Q30362566 | ||
| The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses. | Q30363048 | ||
| DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza H5N1 virus infection. | Q30365874 | ||
| Influenza virus transmission: basic science and implications for the use of antiviral drugs during a pandemic. | Q30367385 | ||
| Quantitative biochemical rationale for differences in transmissibility of 1918 pandemic influenza A viruses. | Q30367860 | ||
| Animal models in influenza vaccine testing. | Q30371058 | ||
| Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense | Q30448808 | ||
| Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infections | Q30462342 | ||
| Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus | Q30482353 | ||
| Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. | Q33243576 | ||
| Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong | Q33644708 | ||
| The role of interferon in influenza virus tissue tropism | Q33785192 | ||
| Molecular correlates of influenza A H5N1 virus pathogenesis in mice | Q33787373 | ||
| Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans | Q33806950 | ||
| Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals | Q33987458 | ||
| Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide | Q34637724 | ||
| Pathogenesis of avian influenza A (H5N1) viruses in ferrets | Q34999473 | ||
| Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells | Q35023814 | ||
| The NS1 gene contributes to the virulence of H5N1 avian influenza viruses | Q35139698 | ||
| Induction and regulation of IFNs during viral infections | Q35867540 | ||
| Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection | Q35900904 | ||
| Pathogenesis of avian influenza (H7) virus infection in mice and ferrets: enhanced virulence of Eurasian H7N7 viruses isolated from humans | Q36099225 | ||
| Highly pathogenic avian influenza H5N1 viruses elicit an attenuated type i interferon response in polarized human bronchial epithelial cells | Q36315601 | ||
| Sialic acid receptor detection in the human respiratory tract: evidence for widespread distribution of potential binding sites for human and avian influenza viruses | Q36316118 | ||
| Type 1 interferons and the virus-host relationship: a lesson in détente . | Q36475884 | ||
| A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity | Q36670254 | ||
| Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation | Q36847687 | ||
| Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. | Q36870919 | ||
| Toward a unified nomenclature system for highly pathogenic avian influenza virus (H5N1). | Q37009433 | ||
| Peginterferon-alpha-2a (40 kD) plus ribavirin: a review of its use in the management of chronic hepatitis C mono-infection | Q37189032 | ||
| Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin | Q37197379 | ||
| Pegylated IFN-alpha2b plus ribavirin for treatment-naive patients coinfected with HCV and HIV. | Q37202832 | ||
| Psychiatric side effects of interferon treatment | Q37239355 | ||
| Interferon-induced Mx protein: a mediator of cellular resistance to influenza virus | Q38181261 | ||
| Exposure to diesel exhaust exacerbates allergen-induced airway responses in guinea pigs | Q39587270 | ||
| Distinct pathogenesis of hong kong-origin H5N1 viruses in mice compared to that of other highly pathogenic H5 avian influenza viruses | Q39588325 | ||
| Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway. | Q40336119 | ||
| The NS1 gene of H5N1 influenza viruses circumvents the host anti-viral cytokine responses | Q40533278 | ||
| Bronchointerstitial pneumonia in guinea pigs following inoculation with H5N1 high pathogenicity avian influenza virus. | Q43175226 | ||
| Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract | Q43176503 | ||
| Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine | Q44910890 | ||
| Histochemical study of glycoconjugates in the nasal mucosa of the rat and guinea pig. | Q45093466 | ||
| Mx1 gene protects mice against the highly lethal human H5N1 influenza virus | Q45401136 | ||
| Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: the role of cytokines and B- and T-cell responses | Q45492687 | ||
| Pathobiology of H5N2 Mexican avian influenza virus infections of chickens. | Q45759088 | ||
| Receptor specificity of influenza virus influences severity of illness in ferrets | Q45771840 | ||
| Lectin histochemistry of the gastric mucosa in normal and Helicobacter pylori infected guinea-pigs | Q46498308 | ||
| Adding interferon to lamivudine enhances the early virologic response and reversion of the precore mutation in difficult-to-treat HBV infection | Q46502474 | ||
| Effects of neuraminidase on airway reactivity in the guinea pig | Q53847745 | ||
| Interferon-induced proteins: identification of Mx proteins in various mammalian species. | Q54305537 | ||
| Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology | Q56987531 | ||
| Antiviral activity of a novel recombinant human interferon-alpha B/D hybrid | Q69344639 | ||
| A recombinant human interferon-alpha B/D hybrid with a broad host-range | Q70166751 | ||
| Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7 | Q77758397 | ||
| P433 | issue | 7 | |
| P921 | main subject | pandemic | Q12184 |
| pathogenesis | Q372016 | ||
| P304 | page(s) | 2851-2861 | |
| P577 | publication date | 2009-01-14 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus shedding | |
| P478 | volume | 83 |
| Q30400787 | A protective role for complement C3 protein during pandemic 2009 H1N1 and H5N1 influenza A virus infection |
| Q30391956 | Activation of the innate immune system provides broad-spectrum protection against influenza A viruses with pandemic potential in mice |
| Q30380435 | An early 'classical' swine H1N1 influenza virus shows similar pathogenicity to the 1918 pandemic virus in ferrets and mice. |
| Q30224564 | Analysis by single-gene reassortment demonstrates that the 1918 influenza virus is functionally compatible with a low-pathogenicity avian influenza virus in mice |
| Q34714853 | Animal Models for Influenza Virus Pathogenesis and Transmission |
| Q27024582 | Animal models for influenza virus pathogenesis, transmission, and immunology |
| Q35998278 | Animal models for influenza virus transmission studies: a historical perspective. |
| Q30383623 | Animal models for the preclinical evaluation of candidate influenza vaccines. |
| Q93241084 | Animal models for the risk assessment of viral pandemic potential |
| Q30407253 | Autopsy series of 68 cases dying before and during the 1918 influenza pandemic peak |
| Q38834987 | Avian Influenza A Viruses: Evolution and Zoonotic Infection |
| Q30224462 | Avian influenza A H5N1 virus: a continuous threat to humans |
| Q34525191 | Biodegradable nanogels for oral delivery of interferon for norovirus infection |
| Q37777544 | Comparative pathology of select agent influenza a virus infections. |
| Q40882442 | Cross-clade protective immune responses of NS1-truncated live attenuated H5N1 avian influenza vaccines |
| Q38061423 | Evasion of influenza A viruses from innate and adaptive immune responses. |
| Q38696286 | Generation and characterization of interferon-lambda 1-resistant H1N1 influenza A viruses. |
| Q28476212 | Guinea pig model for evaluating the potential public health risk of swine and avian influenza viruses |
| Q30427806 | H5N1 pathogenesis studies in mammalian models |
| Q34602475 | Highly pathogenic H5N1 influenza A virus strains provoke heterogeneous IFN-α/β responses that distinctively affect viral propagation in human cells |
| Q57093440 | Importance of 1918 virus reconstruction to current assessments of pandemic risk |
| Q30397203 | Influenza A virus transmission: contributing factors and clinical implications |
| Q28748500 | Influenza Virus Non-Structural Protein 1 (NS1) Disrupts Interferon Signaling |
| Q37857854 | Influenza pharmacotherapy: present situation, strategies and hopes |
| Q38647663 | Influenza virus non‑structural protein 1 inhibits the production of interferon β of alveolar epithelial cells upon the infection of influenza A H1N1. |
| Q33871391 | Influenza-induced production of interferon-alpha is defective in geriatric individuals |
| Q33646273 | Innate immune evasion strategies of influenza viruses |
| Q30415712 | Innovations in modeling influenza virus infections in the laboratory |
| Q37455765 | Intramuscular immunization with a vesicular stomatitis virus recombinant expressing the influenza hemagglutinin provides post-exposure protection against lethal influenza challenge |
| Q30374748 | Intranasal administration of alpha interferon reduces seasonal influenza A virus morbidity in ferrets |
| Q34295681 | Low pathogenic avian influenza isolates from wild birds replicate and transmit via contact in ferrets without prior adaptation |
| Q30456363 | Newer influenza antivirals, biotherapeutics and combinations |
| Q37547355 | Novel H7N9 influenza virus shows low infectious dose, high growth rate, and efficient contact transmission in the guinea pig model |
| Q33663987 | Oromucosal Administration of Interferon to Humans |
| Q39127763 | Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice |
| Q90689409 | Pro-515 of the dynamin-like GTPase MxB contributes to HIV-1 inhibition by regulating MxB oligomerization and binding to HIV-1 capsid |
| Q42207421 | Protection of Atlantic salmon against virus infection by intramuscular injection of IFNc expression plasmid |
| Q30421157 | Reconstruction of the 1918 influenza virus: unexpected rewards from the past |
| Q41831486 | Serological characterization of guinea pigs infected with H3N2 human influenza or immunized with hemagglutinin protein |
| Q45323709 | Syrian hamster as an animal model for the study of human influenza virus infection |
| Q30406570 | The M segment of the 2009 new pandemic H1N1 influenza virus is critical for its high transmission efficiency in the guinea pig model |
| Q57093843 | The Pandemic Threat of Emerging H5 and H7 Avian Influenza Viruses |
| Q37192137 | The battle between influenza and the innate immune response in the human respiratory tract |
| Q30405589 | The ferret as a model organism to study influenza A virus infection |
| Q30401156 | The innate immunity of guinea pigs against highly pathogenic avian influenza virus infection |
| Q36805422 | The tree shrew provides a useful alternative model for the study of influenza H1N1 virus |
| Q30364454 | Transmission in the guinea pig model. |
| Q30381638 | Transmission of pandemic H1N1 influenza virus and impact of prior exposure to seasonal strains or interferon treatment. |
| Q57158941 | Treating Influenza Infection, From Now and Into the Future |
| Q30379985 | Use of animal models to understand the pandemic potential of highly pathogenic avian influenza viruses. |
Search more.